Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Pica

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Annali Dell'Istituto Superiore Di Sanita|September 23, 2021
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practiceLorenzo Ridola, Angelo Zullo, Bruno Laganà, et al.
Strategies in Trauma and Limb Reconstruction|August 22, 2022
Treatment of Unstable Elbow Injuries with a Hinged Elbow Fixator: Subjective and Objective ResultsLuigi Meccariello, Vincenzo Caiaffa, Konrad Mader, et al.
Helicobacter|November 7, 2006
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized studyPaolo Paoluzi, Federico Iacopini, Pietro Crispino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2015
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitisRoberta Pica, Claudio Cassieri, Andrea Cocco, et al.
Frontiers in Immunology|November 15, 2018
CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative ColitisAlessia Butera, Massimo Sanchez, Annamaria Pronio, et al.
Journal of Crohn'S & Colitis|November 22, 2015
Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor ActivityAntonella D'Ambrosio, Andrea Cossu, Antonello Amendola, et al.
Helicobacter|October 11, 2003
Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradicationFederico Iacopini, Adriana Consolazio, Daniela Bosco, et al.
Journal of Clinical Immunology|July 9, 2013
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosisAntonio Picarelli, Marco Di Tola, Raffaele Borghini, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2009
Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinomaPietro Crispino, Piero Luigi Alò, Margherita Rivera, et al.
International Journal of Molecular Sciences|July 26, 2020
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon SignatureRoberto Lande, Anna Mennella, Raffaella Palazzo, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Annali Dell'Istituto Superiore Di Sanita|September 23, 2021
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practiceLorenzo Ridola, Angelo Zullo, Bruno Laganà, et al.
Strategies in Trauma and Limb Reconstruction|August 22, 2022
Treatment of Unstable Elbow Injuries with a Hinged Elbow Fixator: Subjective and Objective ResultsLuigi Meccariello, Vincenzo Caiaffa, Konrad Mader, et al.
Helicobacter|November 7, 2006
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized studyPaolo Paoluzi, Federico Iacopini, Pietro Crispino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2015
A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitisRoberta Pica, Claudio Cassieri, Andrea Cocco, et al.
Frontiers in Immunology|November 15, 2018
CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative ColitisAlessia Butera, Massimo Sanchez, Annamaria Pronio, et al.
Journal of Crohn'S & Colitis|November 22, 2015
Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor ActivityAntonella D'Ambrosio, Andrea Cossu, Antonello Amendola, et al.
Helicobacter|October 11, 2003
Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradicationFederico Iacopini, Adriana Consolazio, Daniela Bosco, et al.
Journal of Clinical Immunology|July 9, 2013
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosisAntonio Picarelli, Marco Di Tola, Raffaele Borghini, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2009
Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinomaPietro Crispino, Piero Luigi Alò, Margherita Rivera, et al.
International Journal of Molecular Sciences|July 26, 2020
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon SignatureRoberto Lande, Anna Mennella, Raffaella Palazzo, et al.
Pageof 6